• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三阴性子宫内膜癌:220例单中心病例系列的发病率及预后

Triple negative endometrial cancer: Incidence and prognosis in a monoinstitutional series of 220 patients.

作者信息

Porzio Rosa, Cordini Claudia, Rodolfi Anna Maria, Brigati Francesca, Ubiali Alessandro, Proietto Manuela, Di Nunzio Camilla, Cavanna Luigi

机构信息

Department of Oncology and Hematology, Piacenza General Hospital, Piacenza I-29121, Italy.

Department of Pathology, Piacenza General Hospital, Piacenza I-29121, Italy.

出版信息

Oncol Lett. 2020 Mar;19(3):2522-2526. doi: 10.3892/ol.2020.11329. Epub 2020 Jan 22.

DOI:10.3892/ol.2020.11329
PMID:32194754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7039155/
Abstract

Endometrial cancer (EC) represents the most frequently occuring gynecological tumor worldwide. The aim of the present study was to estimate the prognostic value of triple negative phenotype (TNP) in EC, and any associations with to pathological and clinical characteristics. The present study includes 220 cases of patients with EC who underwent to surgery at the Guglielmo da Saliceto Hospital of Piacenza (Italy) and the expressions of estrogen receptor (ER), progesterone receptor (PR) and oncoprotein c-erbB-2 (HER2) expression were examined. Pearson's Chi-square and Fisher's exact test were used to evaluate the association of TNP cases with variables associated with a worse prognosis. Progression-free survival (PFS) and overall survival (OS) were analyzed with Kaplan-Meier curves. A total of 26 patients (12%) had a TNP, and these cases had a higher percentage of high-risk histology, an advanced stage of disease at the time of diagnosis, with shorter PFS and OS when compared to non-TNP. The present study confirmed that TNP represents prognostic significance in EC.

摘要

子宫内膜癌(EC)是全球最常见的妇科肿瘤。本研究旨在评估三阴性表型(TNP)在子宫内膜癌中的预后价值,以及与病理和临床特征的任何关联。本研究纳入了220例在意大利皮亚琴察的古列尔莫·达·萨利切托医院接受手术的子宫内膜癌患者,并检测了雌激素受体(ER)、孕激素受体(PR)和癌蛋白c-erbB-2(HER2)的表达。采用Pearson卡方检验和Fisher精确检验来评估TNP病例与预后较差相关变量的关联。采用Kaplan-Meier曲线分析无进展生存期(PFS)和总生存期(OS)。共有26例患者(12%)为TNP,与非TNP患者相比,这些病例的高危组织学比例更高,诊断时疾病分期更晚,PFS和OS更短。本研究证实TNP在子宫内膜癌中具有预后意义。

相似文献

1
Triple negative endometrial cancer: Incidence and prognosis in a monoinstitutional series of 220 patients.三阴性子宫内膜癌:220例单中心病例系列的发病率及预后
Oncol Lett. 2020 Mar;19(3):2522-2526. doi: 10.3892/ol.2020.11329. Epub 2020 Jan 22.
2
The prognostic significance of the triple negative phenotype in endometrial cancer.三阴性表型在子宫内膜癌中的预后意义。
Gynecol Oncol. 2010 Aug 1;118(2):172-5. doi: 10.1016/j.ygyno.2010.04.015. Epub 2010 Jun 1.
3
Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma.肿瘤相关巨噬细胞、表皮生长因子受体与子宫内膜样腺癌的三阴性表型相关。
Pathol Res Pract. 2012 Dec 15;208(12):730-5. doi: 10.1016/j.prp.2012.09.011. Epub 2012 Nov 2.
4
Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience.在生物标志物和乳腺癌新兴个性化医疗时代,乳腺癌的TNM分期系统是否仍然适用——一家机构的10年经验
Breast J. 2015 Mar-Apr;21(2):147-54. doi: 10.1111/tbj.12367. Epub 2015 Jan 20.
5
Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy.接受 CDK4/6 抑制剂联合内分泌治疗作为一线治疗的晚期 ER 高表达 HER2 阴性乳腺癌患者的 PR 状态对预后的影响。
BMC Cancer. 2024 Jul 17;24(1):850. doi: 10.1186/s12885-024-12621-y.
6
HER2-positive endometrial cancer subtype carries poor prognosis.人表皮生长因子受体2阳性子宫内膜癌亚型预后较差。
Clin Transl Sci. 2014 Dec;7(6):482-8. doi: 10.1111/cts.12207. Epub 2014 Sep 9.
7
Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.癌细胞和子宫肌层中雌激素及孕激素受体表达对子宫内膜癌患者生存的影响。
J Obstet Gynaecol. 2018 Jan;38(1):96-102. doi: 10.1080/01443615.2017.1328591. Epub 2017 Aug 1.
8
Age related influence of triple receptor status on metastatic breast cancer post relapse survival.三受体状态对转移性乳腺癌复发后生存的年龄相关影响。
J BUON. 2013 Oct-Dec;18(4):851-8.
9
Triple negative phenomenon in endometrial cancer: recognition criteria and impact on survival.子宫内膜癌中的三阴性现象:识别标准及其对生存的影响。
Ginekol Pol. 2021 Apr 29. doi: 10.5603/GP.a2021.0082.
10
Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis.原发性乳腺癌与相应转移灶之间具有一致三阴性表型的患者预后较差。
J Breast Cancer. 2016 Sep;19(3):268-274. doi: 10.4048/jbc.2016.19.3.268. Epub 2016 Sep 23.

引用本文的文献

1
Clinico-Morphological Features and Immunohistochemical Profile of a Rare Case of Three Synchronous Primary Malignancies in the Female Genital Tract.女性生殖道罕见的三发性原发性恶性肿瘤病例的临床形态学特征及免疫组化分析
Reports (MDPI). 2024 Feb 17;7(1):14. doi: 10.3390/reports7010014.
2
The analysis of hormonal status and vascular and cell proliferation in endometrioid endometrial adenocarcinomas.分析子宫内膜样腺癌中激素状态、血管和细胞增殖的情况。
Rom J Morphol Embryol. 2022 Jan-Mar;63(1):113-120. doi: 10.47162/RJME.63.1.11.
3
Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study.CA-125水平升高及雌激素受体阴性作为子宫内膜癌患者卵巢转移的预后因素:一项回顾性队列研究
Med Sci Monit. 2020 Dec 25;26:e928826. doi: 10.12659/MSM.928826.

本文引用的文献

1
Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online.早期乳腺癌女性的个体化治疗:考虑伴随预后检测 OncotypeDX 和 Adjuvant!Online 的辅助化疗的风险组特异性成本效益分析。
BMC Cancer. 2017 Oct 16;17(1):685. doi: 10.1186/s12885-017-3603-z.
2
A pathways-based prediction model for classifying breast cancer subtypes.一种用于乳腺癌亚型分类的基于通路的预测模型。
Oncotarget. 2017 Jun 17;8(35):58809-58822. doi: 10.18632/oncotarget.18544. eCollection 2017 Aug 29.
3
Triple negative endometrial cancer.三阴性子宫内膜癌
Ginekol Pol. 2017;88(4):212-214. doi: 10.5603/GP.a2017.0040.
4
Immunohistochemical characterisation of molecular subtypes in endometrial cancer.子宫内膜癌分子亚型的免疫组织化学特征
Int J Clin Exp Med. 2015 Nov 15;8(11):21981-90. eCollection 2015.
5
Breast cancer intrinsic subtype classification, clinical use and future trends.乳腺癌内在亚型分类、临床应用及未来趋势。
Am J Cancer Res. 2015 Sep 15;5(10):2929-43. eCollection 2015.
6
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.欧洲肿瘤内科学会-欧洲妇科肿瘤学会-欧洲放射肿瘤学会子宫内膜癌共识会议:诊断、治疗与随访
Int J Gynecol Cancer. 2016 Jan;26(1):2-30. doi: 10.1097/IGC.0000000000000609.
7
Clinical implications of the intrinsic molecular subtypes of breast cancer.乳腺癌内在分子亚型的临床意义。
Breast. 2015 Nov;24 Suppl 2:S26-35. doi: 10.1016/j.breast.2015.07.008. Epub 2015 Aug 5.
8
A clinically applicable molecular-based classification for endometrial cancers.一种适用于临床的子宫内膜癌分子分类方法。
Br J Cancer. 2015 Jul 14;113(2):299-310. doi: 10.1038/bjc.2015.190. Epub 2015 Jun 30.
9
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.子宫内膜癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2013 Oct;24 Suppl 6:vi33-8. doi: 10.1093/annonc/mdt353.
10
Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.激素受体丢失在内膜癌刮宫术中预测淋巴结转移和前瞻性多中心试验中的不良预后。
Eur J Cancer. 2013 Nov;49(16):3431-41. doi: 10.1016/j.ejca.2013.06.016. Epub 2013 Aug 8.